The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to discuss the filing, but founder and CEO Valerie Daggett spoke with GeekWire about AltPep’s progress on its experimental blood test to detect Alzheimer’s disease at the earliest stages.

“We’re going after that first molecular trigger for the pathology,” said Daggett, who is also a UW professor of bioengineering. The 3-year old startup is also developing a diagnostic for Parkinson’s disease and treatments for both conditions…”

Read the full article here: Seattle startup aiming to detect, treat Alzheimer’s and Parkinson’s disease raises cash – GeekWire